Olaya, Felix
Brin, Maeve
Caraballo, Pamela Baez
Halpern, Mina
Jia, Haomiao
Ramírez, Sergio Ozoria
Padilla, Janeth Juarez
Stonbraker, Samantha
Schnall, Rebecca
Funding for this research was provided by:
Agency for Healthcare Research and Quality (R18HS028523, R18HS028523, R18HS028523, R18HS028523, R18HS028523, R18HS028523, R18HS028523, R18HS028523, R18HS028523)
Article History
Received: 12 September 2023
Accepted: 19 December 2023
First Online: 17 January 2024
Declarations
:
: The study was approved by the Columbia University Institutional Review Board (IRB) and the National Council of Bioethics in Health (Consejo Nacional de Bioética en Salud, CONABIOS) in the Dominican Republic. Study participants provide written informed consent and HIPAA authorization at baseline visits prior to enrollment. Researchers follow institutional policies on data collection and management procedures. Current protocol version: August 15, 2023. Any modifications to the protocol are submitted to and approved by the IRB prior to implementation. Adverse events and unintended effects of the trial are tracked by the study principal investigators and reported to the IRB.
: Not applicable.
: The authors declare no competing interests.